Effects on mortality of early vs late administration of convalescent plasma in the treatment of Covid-19

The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first seen in the city of Wuhan, China, in December 2019 and then spread worldwide. On 24 March 2020, the U.S. Food and Drug Administration reported that the use of convalescent plasma (CP) containing antibodies against...

Descripción completa

Detalles Bibliográficos
Autores principales: Kocayiğit, Havva, Demir, Gürkan, Karacan, Alper, Süner, Kezban Özmen, Tomak, Yakup, Yaylacı, Selçuk, Dheir, Hamad, Kalpakci, Yasin, Erdem, Ali Fuat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064905/
https://www.ncbi.nlm.nih.gov/pubmed/33962885
http://dx.doi.org/10.1016/j.transci.2021.103148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064905/
https://www.ncbi.nlm.nih.gov/pubmed/33962885
http://dx.doi.org/10.1016/j.transci.2021.103148

Ejemplares similares